Epigenomic Dysregulation in Schizophrenia: In Search of Disease Etiology and Biomarkers

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2020 Aug 9

PMID 32764320

Citations 34

Authors

Behnaz Khavari

Murray J Cairns

Affiliations

Soon will be listed here.

Abstract

Schizophrenia is a severe psychiatric disorder with a complex array of signs and symptoms that causes very significant disability in young people. While schizophrenia has a strong genetic component, with heritability around 80%, there is also a very significant range of environmental exposures and stressors that have been implicated in disease development and neuropathology, such as maternal immune infection, obstetric complications, childhood trauma and cannabis exposure. It is postulated that epigenetic factors, as well as regulatory non-coding RNAs, mediate the effects of these environmental stressors. In this review, we explore the most well-known epigenetic marks, including DNA methylation and histone modification, along with emerging RNA mediators of epigenomic state, including miRNAs and lncRNAs, and discuss their collective potential for involvement in the pathophysiology of schizophrenia implicated through the postmortem analysis of brain tissue. Given that peripheral tissues, such as blood, saliva, and olfactory epithelium have the same genetic composition and are exposed to many of the same environmental exposures, we also examine some studies supporting the application of peripheral tissues for epigenomic biomarker discovery in schizophrenia. Finally, we provide some perspective on how these biomarkers may be utilized to capture a signature of past events that informs future treatment.

Citing Articles

Very Early-Onset Schizophrenia with Accompanying Obsessive-Compulsive Symptoms: A Case Report of a Female with 16p13.11 Duplication.

Kiziltan K, Ozbezen Kiziltan E, Yerlikaya Oral E, Akgun Dogan O, Ersoy M, Karacetin G Psychiatry Clin Psychopharmacol. 2024; 34(4):356-360.

PMID: 39629735 PMC: 11744378. DOI: 10.5152/pcp.2024.24949.

The Association and Prognostic Implications of Long Non-Coding RNAs in Major Psychiatric Disorders, Alzheimer's Diseases and Parkinson's Diseases: A Systematic Review.

Zhu L, Guo M, Li K, Guo C, He K Int J Mol Sci. 2024; 25(20).

PMID: 39456775 PMC: 11507000. DOI: 10.3390/ijms252010995.

Autism spectrum disorder: difficulties in diagnosis and microRNA biomarkers.

Martinez B, Peplow P Neural Regen Res. 2024; 20(10):2776-2786.

PMID: 39314171 PMC: 11826456. DOI: 10.4103/NRR.NRR-D-24-00712.

A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automated machine learning.

Karaglani M, Agorastos A, Panagopoulou M, Parlapani E, Athanasis P, Bitsios P Transl Psychiatry. 2024; 14(1):257.

PMID: 38886359 PMC: 11183091. DOI: 10.1038/s41398-024-02946-4.

The Correlation Between Peripheral Blood Micro-Ribonucleic Acid Expression Level and Personality Disorder in Patients with Schizophrenia.

Wei H, Kong L, Zhu X, Chen S, Zhang L, Niu W Alpha Psychiatry. 2024; 25(1):23-29.

PMID: 38799488 PMC: 11114240. DOI: 10.5152/alphapsychiatry.2024.231216.

References

Hu J, Xu J, Pang L, Zhao H, Li F, Deng Y . Systematically characterizing dysfunctional long intergenic non-coding RNAs in multiple brain regions of major psychosis. Oncotarget. 2016; 7(44):71087-71098. PMC: 5342065. DOI: 10.18632/oncotarget.12122. View

Watkeys O, Cohen-Woods S, Quide Y, Cairns M, Overs B, Fullerton J . Derivation of poly-methylomic profile scores for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2020; 101:109925. DOI: 10.1016/j.pnpbp.2020.109925. View

Iwamoto K, Bundo M, Yamada K, Takao H, Iwayama-Shigeno Y, Yoshikawa T . DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci. 2005; 25(22):5376-81. PMC: 6725011. DOI: 10.1523/JNEUROSCI.0766-05.2005. View

Auta J, Smith R, Dong E, Tueting P, Sershen H, Boules S . DNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients. Schizophr Res. 2013; 150(1):312-8. PMC: 4121849. DOI: 10.1016/j.schres.2013.07.030. View

Walton E, Hass J, Liu J, Roffman J, Bernardoni F, Roessner V . Correspondence of DNA Methylation Between Blood and Brain Tissue and Its Application to Schizophrenia Research. Schizophr Bull. 2015; 42(2):406-14. PMC: 4753587. DOI: 10.1093/schbul/sbv074. View

Melas P, Rogdaki M, Osby U, Schalling M, Lavebratt C, Ekstrom T . Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J. 2012; 26(6):2712-8. DOI: 10.1096/fj.11-202069. View

Beveridge N, Tooney P, Carroll A, Gardiner E, Bowden N, Scott R . Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet. 2008; 17(8):1156-68. DOI: 10.1093/hmg/ddn005. View

Owen M, Sawa A, Mortensen P . Schizophrenia. Lancet. 2016; 388(10039):86-97. PMC: 4940219. DOI: 10.1016/S0140-6736(15)01121-6. View

Chen S, Sun X, Niu W, Kong L, He M, Li W . Aberrant Expression of Long Non-Coding RNAs in Schizophrenia Patients. Med Sci Monit. 2016; 22:3340-51. PMC: 5034886. DOI: 10.12659/msm.896927. View

10.

Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis M, Nervi C . A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell. 2005; 123(5):819-31. DOI: 10.1016/j.cell.2005.09.023. View

11.

Yap K, Li S, Munoz-Cabello A, Raguz S, Zeng L, Mujtaba S . Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38(5):662-74. PMC: 2886305. DOI: 10.1016/j.molcel.2010.03.021. View

12.

Lai C, Yu S, Hsieh M, Chen C, Chen H, Wen C . MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. PLoS One. 2011; 6(6):e21635. PMC: 3126851. DOI: 10.1371/journal.pone.0021635. View

13.

Zen K, Zhang C . Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev. 2012; 32(2):326-48. DOI: 10.1002/med.20215. View

14.

Hannon E, Dempster E, Viana J, Burrage J, Smith A, Macdonald R . An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation. Genome Biol. 2016; 17(1):176. PMC: 5004279. DOI: 10.1186/s13059-016-1041-x. View

15.

Mahmoudi E, Cairns M . MiR-137: an important player in neural development and neoplastic transformation. Mol Psychiatry. 2016; 22(1):44-55. PMC: 5414082. DOI: 10.1038/mp.2016.150. View

16.

Horiuchi Y, Kano S, Ishizuka K, Cascella N, Ishii S, Talbot Jr C . Olfactory cells via nasal biopsy reflect the developing brain in gene expression profiles: utility and limitation of the surrogate tissues in research for brain disorders. Neurosci Res. 2013; 77(4):247-50. PMC: 4097863. DOI: 10.1016/j.neures.2013.09.010. View

17.

Geaghan M, Cairns M . MicroRNA and Posttranscriptional Dysregulation in Psychiatry. Biol Psychiatry. 2015; 78(4):231-9. DOI: 10.1016/j.biopsych.2014.12.009. View

18.

Friston K, Frith C . Schizophrenia: a disconnection syndrome?. Clin Neurosci. 1995; 3(2):89-97. View

19.

Marshall C, Howrigan D, Merico D, Thiruvahindrapuram B, Wu W, Greer D . Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 2016; 49(1):27-35. PMC: 5737772. DOI: 10.1038/ng.3725. View

20.

OConnell R . MicroRNAs function on a new level. Blood. 2012; 119(17):3875-6. DOI: 10.1182/blood-2012-02-410977. View